The development of extracorporeal life support technology has added a new dimension to
the care of critically ill patients who fail conventional treatment options. Extracorporeal …

The artificial lung (AL) technology is one of the membrane-based artificial organs that partly
augments lung functions, ie blood oxygenation and CO 2 removal. It is generally employed …

Extracorporeal membrane oxygenation (ECMO) is used in critical care to manage patients
with severe respiratory and cardiac failure. ECMO brings blood from a critically ill patient into …

Biomedical gas exchange membranes used for blood oxygenation, including extracorporeal
membrane oxygenators (ECMO) and artificial lung technology, have suffered from the …

Recent global events such as COVID‐19 pandemic amid rising rates of chronic lung
diseases highlight the need for safer, simpler, and more available treatments for respiratory …

Extracorporeal membrane oxygenation (ECMO) is an invasive and last-resort treatment for
circulatory and respiratory failure. Prolonged ECMO support can disrupt the coagulation and …

A new generation of extracorporeal artificial organ support technologies, collectively known
as extracorporeal life support (ECLS) devices, is being developed for diverse applications to …

Biomedical devices are prone to blood clot formation (thrombosis), and liquid‐infused
surfaces (LIS) are effective in reducing the thrombotic response. However, the mechanisms …

Medical devices that require substantial contact between blood and a foreign surface would
be dramatically safer if constructed from materials that prevent clot formation and …

Liquid infused surfaces (LIS) hold remarkable potential in anticoagulation. However, liquid
loss of LIS in the bloodstream remains a challenge toward its clinical application. Here …